Form 3 Morrison Patricia

3 - Initial statement of beneficial ownership of securities

Published: 2014-11-17 07:57:49
Submitted: 2014-11-17
Period Ending In: 2014-11-05
wf-form3_141622905865537.html FORM 3


>

SEC FORM 3

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
MORRISON PATRICIA

(Last) (First) (Middle)
7000 CARDINAL PLACE

(Street)
DUBLIN OH 43017

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/05/2014
3. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Information Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares 30,797 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (1) 08/15/2021 Common Shares 36,042 41.6 D
Employee Stock Option (right to buy) (2) 08/15/2022 Common Shares 43,959 39.81 D
Employee Stock Option (right to buy) (3) 08/15/2023 Common Shares 34,158 51.49 D
Employee Stock Option (right to buy) (4) 08/15/2024 Common Shares 24,611 71.43 D
Explanation of Responses:
1. These options are currently exercisable.
2. Two-thirds of these options are currently exercisable, and one-third will vest on 8/15/2015.
3. One-third of these options are currently exercisable, one-third will vest on 8/15/2015, and one-third will vest on 8/15/2016.
4. These options vest in three equal annual installments beginning on 8/15/2015.
Remarks:
EXHIBIT LIST: EX-24 Morrison POA
/s/ James E. Barnett, Attorney-in-fact 11/17/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
1
wf-form3_141622905865537.xml FORM 3
Schema Version:
X0206
Document Type:
3
Period Of Report:
2014-11-05
No Securities Owned:
0

Issuer

Issuer Cik
0000721371
Issuer Name
CARDINAL HEALTH INC
Issuer Trading Symbol
CAH

Reporting Owner

Reporting Owner Id

Rpt Owner Cik
0001204081
Rpt Owner Name
MORRISON PATRICIA

Reporting Owner Address

Rpt Owner Street1
7000 CARDINAL PLACE
Rpt Owner City
DUBLIN
Rpt Owner State
OH
Rpt Owner Zip Code
43017

Reporting Owner Relationship

Is Director
0
Is Officer
1
Is Ten Percent Owner
0
Is Other
0
Officer Title
Chief Information Officer

Non Derivative Holding

Security Title
Common Shares
Shares Owned Following Transaction
30797
Direct Or Indirect Ownership
D

Derivative Holding

Security Title
Employee Stock Option (right to buy)
Conversion Or Exercise Price
41.6
@attributes Id
F1
Expiration Date
2021-08-15

Underlying Security

Underlying Security Title
Common Shares
Underlying Security Shares
36042.0
Direct Or Indirect Ownership
D
Security Title
Employee Stock Option (right to buy)
Conversion Or Exercise Price
39.81
@attributes Id
F2
Expiration Date
2022-08-15

Underlying Security

Underlying Security Title
Common Shares
Underlying Security Shares
43959.0
Direct Or Indirect Ownership
D
Security Title
Employee Stock Option (right to buy)
Conversion Or Exercise Price
51.49
@attributes Id
F3
Expiration Date
2023-08-15

Underlying Security

Underlying Security Title
Common Shares
Underlying Security Shares
34158.0
Direct Or Indirect Ownership
D
Security Title
Employee Stock Option (right to buy)
Conversion Or Exercise Price
71.43
@attributes Id
F4
Expiration Date
2024-08-15

Underlying Security

Underlying Security Title
Common Shares
Underlying Security Shares
24611.0
Direct Or Indirect Ownership
D

Footnote

0
These options are currently exercisable.
1
Two-thirds of these options are currently exercisable, and one-third will vest on 8/15/2015.
2
One-third of these options are currently exercisable, one-third will vest on 8/15/2015, and one-third will vest on 8/15/2016.
3
These options vest in three equal annual installments beginning on 8/15/2015.
Remarks:
EXHIBIT LIST: EX-24 Morrison POA

Owner Signature

Signature Name
/s/ James E. Barnett, Attorney-in-fact
Signature Date
2014-11-17
ex-24.htm MORRISON POA


> ENT> EX-24 2 ex-24.htm MORRISON POA
PATRICIA B. MORRISON
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
I hereby make, constitute and appoint each of Stephen T. Falk, John M. Adams, Jr., James E. Barnett, Elaine S. Natsis, and Laura C. Vaughn, each acting individually, as the undersigned's true and lawful attorney-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to:
(1)    prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Cardinal Health, Inc., an Ohio corporation (the "Company"), with the United States Securities and Exchange Commission (the "SEC"), any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the United States Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act");
(2)    prepare and execute in the undersigned's name and on the undersigned's behalf, and to submit to the SEC a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Exchange Act or any rule or regulation of the SEC;
(3)    prepare, execute, acknowledge, deliver and file Form 144s (including any amendments or supplements thereto) with respect to the sale of securities of the Company by the undersigned, with the SEC, any national securities exchanges and the Company, as considered necessary or advisable under Rule 144 of the Securities Act of 1933 and the rules and regulations promulgated thereunder, as amended from time to time;
(4)    seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the attorney-in-fact and approves and ratifies any such release of information; and
(5)    perform any and all other acts which in the discretion of such attorney-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing.
The undersigned acknowledges that:
(1)    this Limited Power of Attorney authorizes, but does not require, each such attorney-in-fact to act in his discretion on information provided to such attorney-in-fact without independent verification of such information;
(2)    any documents prepared and/or executed by each such attorney-in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his discretion, deems necessary or desirable;
(3)    neither the company nor such attorney-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and
(4)    this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation, the reporting requirements under Section 16 of the Exchange Act.
The undersigned hereby gives and grants each of the foregoing attorneys-in-fact full power and authority to do and perform all and every act and thing whatsoever required, necessary or appropriate to be done in connection with the undersigned and the undersigned also hereby ratifies all that each such attorney-in-fact shall lawfully do or cause to be done by virtue of this Limited Power of Attorney.
This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to each such attorney-in-fact.
    IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be executed as of this 24 day of October, 2014.

/s/ Patricia B. Morrison
Signature
Additional Files
FileSequenceDescriptionTypeSize
0000721371-14-000266.txt   Complete submission text file   12734
$CAH

© 2019 SEC.report
SEC CFR Title 17 of the Code of Federal Regulations.